Darija Hofmann1, Fowzia Ibrahim2, Diana Rose3, David L Scott2, Andrew Cope2, Til Wykes3, Heidi Lempp2. 1. Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK. 2. Academic Department of Rheumatology, King's College London, London, UK. 3. Institute of Psychiatry, King's College London, London, UK.
Abstract
BACKGROUND: Service-user partnerships in research exist in mental health, but there have been few advances in other disciplines, apart from cancer. OBJECTIVES: To develop a patient-generated expectancy measure for new treatments in rheumatoid arthritis (RA), using a participatory method. METHOD: Stage 1: three repeated focus groups and two expert panels with patients with RA conducted by a patient researcher to generate items for the draft questionnaire. Stage 2: feasibility study of draft scale with consecutive outpatient attendees. RESULTS: Patients identified 21 dimensions of new treatment expectations, grouped into (i) physical, (ii) psycho-social and (iii) expectations relating to the impact of treatment. This resulted in a draft instrument assessed in a feasibility study. DISCUSSION AND CONCLUSION: The participatory research method was useful in involving patients actively in research and to produce collaboratively a feasible, valid and acceptable measure in RA. The scale will be included in a longitudinal observational study, with newly diagnosed patients, to assess (i) whether the new scale demonstrates sensitivity to change for expectations when receiving new treatment and (ii) participants' completion rate of the new scale compared with five instruments included in the future study.
BACKGROUND: Service-user partnerships in research exist in mental health, but there have been few advances in other disciplines, apart from cancer. OBJECTIVES: To develop a patient-generated expectancy measure for new treatments in rheumatoid arthritis (RA), using a participatory method. METHOD: Stage 1: three repeated focus groups and two expert panels with patients with RA conducted by a patient researcher to generate items for the draft questionnaire. Stage 2: feasibility study of draft scale with consecutive outpatient attendees. RESULTS:Patients identified 21 dimensions of new treatment expectations, grouped into (i) physical, (ii) psycho-social and (iii) expectations relating to the impact of treatment. This resulted in a draft instrument assessed in a feasibility study. DISCUSSION AND CONCLUSION: The participatory research method was useful in involving patients actively in research and to produce collaboratively a feasible, valid and acceptable measure in RA. The scale will be included in a longitudinal observational study, with newly diagnosed patients, to assess (i) whether the new scale demonstrates sensitivity to change for expectations when receiving new treatment and (ii) participants' completion rate of the new scale compared with five instruments included in the future study.
Authors: M Ahlmén; U Nordenskiöld; B Archenholtz; I Thyberg; R Rönnqvist; L Lindén; A-K Andersson; K Mannerkorpi Journal: Rheumatology (Oxford) Date: 2004-09-20 Impact factor: 7.580
Authors: Elizabeth Hulen; Ayla Ervin; Allison Schue; Gina Evans-Young; Somnath Saha; Edward H Yelin; Jennifer L Barton Journal: Musculoskeletal Care Date: 2016-12-14
Authors: Naomi H Martin; Fowzia Ibrahim; Brian Tom; James Galloway; Allan Wailoo; Jonathan Tosh; Heidi Lempp; Louise Prothero; Sofia Georgopoulou; Jackie Sturt; David L Scott Journal: Trials Date: 2017-12-08 Impact factor: 2.279